Skip to main content

Table 1 Baseline demographics

From: International Analgesia, Sedation, and Delirium Practices: a prospective cohort study

  2010
n = 7323
2016
n = 6958
Age 63 (49–74) 64 (50–75)
Male 4571 (62%) 4347 (62%)
BMI 25.5 (22.9–28.9) 25.1 (22.6–28.3)
SAPSII 45 (33–58) 44 (32–58)
Region
 USA/Canada 825 (11.3%) 322 (4.6%)
 Europe 2931 (40.0%) 2677 (38.5%)
 Africa 133 (1.8%) 169 (2.4%)
 Asia 1226 (16.7%) 1816 (26.1%)
 Latin America 1576 (21.5%) 1809 (26.0%)
 Australia/New Zealand 632 (8.6%) 165 (2.4%)
Reason for ventilation
 COPD exacerbation 336 (4.6%) 323 (4.6%)
 Asthma 80 (1.1%) 44 (0.6%)
 Other chronic pulmonary disease 87 (1.2%) 116 (1.7%)
Comaa
 Metabolic 265 (3.8%) 287 (4.4%)
 Overdose/intoxication 211 (3.0%) 197 (3.0%)
 Hemorrhagic stroke 470 (6.7%) 434 (6.6%)
 Ischemic stroke 214 (3.1%) 199 (3.0%)
 Brain trauma 302 (4.3%) 378 (5.7%)
Neuromuscular disease 74 (1.0%) 93 (1.4%)
Acute respiratory failure
 ARDS 256 (3.5%) 284 (4.1%)
 Postoperative 1702 (23.2%) 1538 (22.1%)
 CHF 399 (5.4%) 346 (5.0%)
 Aspiration 188 (2.6%) 167 (2.4%)
 Pneumonia 697 (9.5%) 737 (10.6%)
 Sepsis 715 (9.8%) 700 (10.6%)
 Trauma 347 (4.7%) 296 (4.3%)
 Cardiac arrest 473 (6.8%) 443 (6.7%)
 Other ARF 400 (5.5%) 261 (3.8%)
  1. Continuous variables reported as median (IQR). Categorical variables reported as n (%)
  2. aComa subtype was missing in 341 and 384 patients in 2010 and 2016, respectively
  3. Definitions of abbreviations: ARDS acute respiratory distress syndrome, ARF acute respiratory failure, CHF congestive heart failure, BMI body mass index, SAPS simplified acute physiology score